MedTrace Logo

Effect of Oxytocin and Vasopressin Antagonists on Uterine Contractions

NCT00587327 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 125

Last updated 2017-06-21

No results posted yet for this study

Summary

The main purpose of this clinical research trial was to evaluate the effects of barusiban and atosiban compared to placebo on luteal phase uterine contractions in oocyte donors supplemented with progesterone.

Conditions

  • In Vitro Fertilisation (IVF) Treatment

Interventions

DRUG

Barusiban

Solution for IV treatment. Bolus and infusion for 4 hours

DRUG

Atosiban

Solution for IV administration. Bolus and infusion for 4 hours

DRUG

Placebo

Saline solution for IV administration. Bolus and infusion for 4 hours.

Sponsors & Collaborators

  • Ferring Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Clinical Development Support · Ferring Pharmaceuticals

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2008-05-31
Completion
2008-09-30

Countries

  • Belgium
  • Czechia
  • Spain

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00587327 on ClinicalTrials.gov